RESMED INC — Director's Dealing 2010

Nov 15, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-11-11

Reporting Person: Farrell Michael J. (Sr. VP Sleep SBU)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-11-11	ResMed Common Stock	M	21047	$23.095	Acquired	41482.732	Direct
2010-11-11	ResMed Common Stock	S	21047	$33.70	Disposed	20435.732	Direct
2010-11-11	ResMed Common Stock	F	3668	$33.70	Disposed	16890.613	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-11-11	ResMed Common Stock Options	$23.095	M	21047	Disposed	2013-11-10	ResMed Common Stock (21047)	Direct
2010-11-11	ResMed Common Stock Options	$33.70	A	75000	Acquired	2017-11-11	ResMed Common Stock (75000)	Direct

Footnotes

F1: Represents first date options became exercisable.

F2: Represents first date 1/4 of the options become exercisable. Thereafter options will continue to vest 1/4 annually until fully vested.

F3: Disposition to issuer for tax withholding upon vesting of Performance-based Restricted Stock Units granted on December 17, 2009.

F4: Includes 122.881 shares purchased on October 30, 2010, pursuant to ResMed's Employee Stock Purchase Plan.